← SynDRA
BELVARAFENIB
SynDRA canonical compound SYN0038676 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | ARAF | BRAF | NRAS |
| Mechanism of action | raf inhibitor |
| Indication | melanoma |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- RAF1 INHIBITOR
- RAF serine/threonine protein kinase inhibitor
- BRAF INHIBITOR
- ARAF INHIBITOR
- raf inhibitor
Cross-references
Synonyms
- UNII-31M3WLJ3KG
- 31M3WLJ3KG
- 4-Amino-N-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide
- 4-amino-N-{1-[(3-chloro-2-fluorophenyl)amino]-6-methylisoquinolin-5-yl}thieno[3,2-d]pyrimidine-7-carboxamide
- CHEMBL3977543
- SCHEMBL15066408
- BDBM185591
- BCP31233
- EX-A3061
- s8853
- HM95573
- BS-15746
- HY-109080
- CS-0039257
- Belvarafenib(GDC5573, HM95573, RG6185)
- US9156852, 116
- 4-Amino-N-(1-(3-chloro-2-fluorophenylamino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide
- 4-amino-N-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide
- V1Y
- BELVARAFENIB [INN]
- BELVARAFENIB [WHO-DD]
- RG6185
- Example 116 [WO2013100632A1]
- Example 116 (WO2013100632A1)
- belvarafenibum
- RefChem:116928
- GDC-5573
- Belvarafenib?
- C23H16ClFN6OS
- Belvarafenib (HM95573)
- orb1301634
- SCHEMBL29381668
- SCHEMBL29386453
- SCHEMBL30134683
- GTPL11544
- GLXC-21607
- WHC11323
- MFCD31731098
- AKOS037648828
Look up BELVARAFENIB in the interactive SynDRA portal →